Medical treatment of endometriosis: an update

Laila Ezzat


Endometriosis is defined as the presence of endometrial-like tissue (glands and stroma) outside the uterus, which induces a chronic inflammatory reaction, scar tissue, and adhesions that may distort a woman’s pelvic anatomy. Endometriosis is primarily found in young women, but its occurrence is not related to ethnic or social group distinctions. Patients with endometriosis mainly complain of pelvic pain, dysmenorrhea, and dyspareunia. Endometriosis is a very common debilitating disease that occurs in 6 to 10% of the general female population; in women with pain, infertility, or both, the frequency is 35-50%. This is an evidence based narrative review conducted by searching Medline up to (2017) and other online articles from Pubmed, Google scholar by using terms like Endometriosis, management, evidence based, updated treatment, pharmacoceutical hormon treatment and non-hormonal treatment. Articles were selected based on their currency and relevance to the discussion. Numerous cofactors can play a role in the progression and maintenance of endometriosis, which is thus a complex multifactorial disease. Hormonal therapy represents the treatment of choice in patients with endometriosis; with this in mind, we could consider CAM a supplementary option to be added to hormonal treatment, or as a valuable opportunity for those women in whom medical therapy is contraindicated.


Endometriosis, Evidence based, Management, Pharmacoceutical hormone treatment, Non-hormonal treatment, Updated treatment

Full Text:



Kennedy S, Bergqvist A, Chapron C, D’Hooghe T, Dunselman G, Saridogan E, et al. ESHRE guideline on the diagnosis and management of endometriosis. Hum Reprod. 2005;20(10):2698-704.

Rock JA, Markham SM. Pathogenesis of endometriosis. Lancet. 1992;340:1264-7.

Giudice LC, Kao LC. Endometriosis. Lancet. 2004;364(9447):789-99.

Daly S (October 18, 2004). Endometrioma/Endometriosis. WebMD. Retrieved 2006.

Simoens S, Hummelshoj L, D’Hooghe T. Endometriosis: cost estimates and methodological perspective. Hum Reprod Update. 2007;13:394-404.

Huang HY. Medical treatment of endometriosis. Chang Gung Med J. 2008;31(5):431-40.

Redwine DB. Conservative laparoscopic excision of endometriosis by sharp dissection: life table analysis and reoperation and persistent or recurrent disease. Fertil Steril. 1991;56:628-34.

Busacca M, Fedele L, Bianchi S, Candiani M, Agnoli B, Raffaelli R, Vignali M. Surgical treatment of recurrent endometriosis: laparotomy versus laparoscopy. Human reproduction (Oxford, England). 1998;13(8):2271-4.

Gambone JC, Mittman BS, Munro MG, Scialli, AR, Winkel CA. Chronic Pelvic Pain/Endometriosis Working Group. Consensus statement for the management of chronic pelvic pain and endometriosis: proceedings of an expert-panel consensus process. Fertil Steril. 2002;78:961-72.

The Practice Committee of the American Society for Reproductive Medicine American Society for Reproductive Medicine, Birmingham, Alabama Treatment of pelvic pain associated with endometriosis: a committee opinion. Fertil Steril. 2014;101(4):927-35.

Olive DL. Medical therapy of endometriosis. Semin Reprod Med. 2003;21:209-22.

Razzi S, Luisi S, Ferretti C, Calonaci F, Gabbanini M, Mazzini M. et al. Use of a progestogen-only preparation containing desogestrel in the treatment of recurrent pelvic pain after conservative surgery for endometriosis. Eur J Obstet Gynecol Reprod Biol. 2007;135:188-90.

Vercellini P, Trespidi L, Colombo A, Vendola N, Marchini M, and Crosignani PG. A gonadotropin-releasing hormone agonist versus a low-dose oral contraceptive for pelvic pain associated with endometriosis. Fertil Steril. 1993;60:75-9.

Vercellini P, Frontino G, De Giorgi O, Pietropaolo G, Pasin R, and Crosignani PG. Continuous use of an oral contraceptive for endometriosis-associated recurrent dysmenorrhea that does not respond to a cyclic pill regimen. Fertil Steril. 2003;80:560-3.

Vercellini P, Cortesi I, and Crosignani PG. Progestogens for symptomatic endometriosis: a critical analysis of the evidence. Fertil Steril. 1997;68:393-401.

McCormack PL. Dienogest. A review of its use in the treatment of endometriosis. Drugs. 2010;70:2073-88.

Vercellini P, Frontino G, de Giorgi O, Aimi G, Zaina B, and Crosignani PG. Comparison of a levonorgestrel-releasing intrauterine device versus expectant management after conservative surgery for symptomatic endometriosis: a pilot study. Fertil Steril. 2003;80:305-9.

Fedele L, Bianchi S, Zanconato G, Portuese A, and Raffaelli R. Use of a levonorgestrel-releasing intrauterine device in the treatment of rectovaginal endometriosis. Fertile Steril. 2001;75:485-8.

Lockhat FB, Emembolu JO, and Konje JC. The evaluation of the effectiveness of an intrauterine-administered progestogen (levonorgestrel) in the symptomatic treatment of endometriosis and in the staging of the disease. Hum Reprod. 2004;19:179-84.

BayogluTekin Y, Dilbaz B, Altinbas SK, and Dilbaz S. Postoperative medical treatment of chronic pelvic pain related to severe endometriosis: levonorgestrel-releasing intrauterine system versus gonadotropin-releasing hormone analogue. Fertil Steril. 2011;95: 492-6.

Brown J, Pan A, and Hart RJ. Gonadotrophin-releasing hormone analogues for pain associated with endometriosis. Cochrane Database Syst Rev. 2010;12:CD008475

Waller KG and Shaw RW. Gonadotropin-releasing hormone analogues for the treatment of endometriosis: long-term follow-up. Fertil Steril. 1993;59:511-5.

Barbieri RL. Endometriosis and the estrogen threshold theory: relation to surgical and medical treatment. J Reprod Med. 1998;43:287-92.

Pavone ME and Bulun SE. Aromatase inhibitors for the treatment of endometriosis. Fertil Steril. 2012;98:1370-9.

Farquhar C, Prentice A, Singla AA, Selak V. Danazol for pelvic pain associated with endometriosis. The Cochrane Library. 2007.

Ferrero S, Tramalloni D, Venturini PL, and Remorgida V. Vaginal danazol for women with rectovaginal endometriosis and pain sympotms persisting after insertion of a levonorgestrol-releasing intrauterine device. Int J Gynecol Obstet. 2011;113:116-9.

Mizutani T, Nishiyama S, Amakawa I, Watanabe A, Nakamuro K, and Terada N. Danazol concentrations in ovary, uterus, and serum and their effect on the hypothalamic-pituitary-ovarian axis during vaginal administration of a danazol suppository. Fertil Steril. 1995;63:1184-9.

Igarashi M, Iizuka M, Abe Y, and Ibuki Y. Novel vaginal danazol ring therapy for pelvic endometriosis, in particular deeply infiltrating endometriosis. Hum Reprod. 1998;13:1952-6.

Cobellis L, Razzi S, Fava A, Severi FM, Igarashi M, and Petraglia F. A danazol-loaded intrauterine device decreases dysmenorrhea, pelvic pain, and dyspareunia associated with endometriosis. Fertil Steril. 2004;82:239-40.

Davis L, Kennedy SS, Moore J, and Prentice A. Modern combined oral contraceptives for pain associated with endometriosis. Cochrane Database Syst Rev. 2007;3:CD001019.

Brown J, Kives S, and Akhtar M. Progestagens and anti-progestagens for pain associated with endometriosis. Cochrane Database Syst Rev. 2012;3:CD002122

Nawathe A, Patwardhan S, Yates D, Harrison GR, and Khan KS. Systematic review of the effects of aromatase inhibitors on pain associated with endometriosis. Br J Obstet Gynecol. 2008;115:818-22.

Soysal S, Soysal ME, Ozer S, Gul N, and Gezgin T. The effects of post-surgical administration of goserelin plus anastrozole compared to goserelin alone in patients with severe endometriosis: a prospective randomized trial. Hum Reprod. 2004;19:160-7.

Flower A, Liu JP, Lewith G, Little P, Li Q. Chinese herbal medicine for endometriosis. Cochrane Database Syst Rev. 2012;5:CD006568.

Lu D, Song H, Li Y, Clarke J, Shi G. Pentoxifylline for endometriosis. Cochrane Database Syst Rev (Online). 2012;1:CD007677.

Practice bulletin no. 114 management of endometriosis. Obstet Gynecol. 2010;116(1):223-36.

Laschke MW, Menger MD. Anti-angiogenic treatment strategies for the therapy of endometriosis. Human Reprod Update. 2012;18(6):682-702.

Canny GO, Lessey BA. The role of lipoxin A4 in endometrial biology and endometriosis. Mucosal Immunol. 2013;6(3):439-50.

Streuli I, de Ziegler D, Santulli P. An update on the pharmacological management of endometriosis. Expert Opin Pharmacother. 2013;14(3):291-305.

Valiani M, Ghasemi N, Bahadoran P, Heshmat R. The effects of massage therapy on dysmenorrhea caused by endometriosis. Iran J Nurs Midwifery Res. 2010;15(4):167-71.

Vercellini P, Buggio L, Berlanda N, Barbara G, Somigliana E, Bosari S. Estrogen-progestins and progestins for the management of endometriosis. Fertil Steril. 2016;106(7):1552-71.

Vercellini P, Viganò P, Somigliana E, Fedele L. Endometriosis: pathogenesis and treatment. Nat Rev Endocrinol. 2014;10(5):261-75.

Kong S, Zhang YH, Liu CF. The complementary and alternative medicine for endometriosis: a review of utilization and mechanism. Evid Based Complement Alternat Med. 2014;2014:146383.

Buggio L, Barbara G, Facchin F, Frattaruolo MP, Aimi G, and Berlanda N. Self-management and psychological-sexological interventions in patients with endometriosis: strategies, outcomes, and integration into clinical care. Int J Womens Health. 2017;9:281-93.

World Health Organization General guidelines for methodologies on research and evaluation of traditional medicine. 2000. Available from:

Fisher C, Adams J, Hickman L, Sibbritt D. The use of complementary and alternative medicine by 7427 Australian women with cyclic perimenstrual pain and discomfort: a cross-sectional study. BMC Complement Altern Med. 2016;16:129.